全球118款生物药即将失去专利或独占权,生物类似药的“泼天富贵”来了?

第一财经
Sep 09

中国市场中生物类似药面临集采降价的潜在压力,而市场的增长潜力在哪?  9月8日,在复宏汉霖开放日活动上,波士顿咨询公司(BCG)合伙人杜菁表示,全球正迎来生物类似药发展的重大窗口期,重磅原研药集中进入专利悬崖,叠加欧美政策持续利好,预计2035年全球生物类似药市场规模将突破2400亿美元。  BCG方面预计,未来十年,全球有118款生物药即将失去专利或独占权,这将是史上最大的生物药专利悬崖潮。专利...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10